What is it about a Viagra company that makes them more responsible for solving global health issues than e.g. IKEA?
Yes, for some reason the proposal combines a carbon-trading-style-scheme with a decision to make pharmaceutical companies pay for it all. The latter seems to be totally separable—just distribute the credits in proportion (at a slightly lower ratio than the target) to revenues! This would also significantly help address the problem I outlined in the other comment, by reducing the incentive just to shift revenue ex-US.
Yes, for some reason the proposal combines a carbon-trading-style-scheme with a decision to make pharmaceutical companies pay for it all. The latter seems to be totally separable—just distribute the credits in proportion (at a slightly lower ratio than the target) to revenues! This would also significantly help address the problem I outlined in the other comment, by reducing the incentive just to shift revenue ex-US.